TwinBeech Capital’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-81,581
Closed -$483K 693
2022
Q2
$483K Buy
+81,581
New +$908K 0.02% 420
2022
Q1
Sell
-66,168
Closed -$2.16M 590
2021
Q4
$2.16M Buy
66,168
+53,401
+418% +$2.15M 0.12% 218
2021
Q3
$524K Sell
12,767
-8,201
-39% -$298K 0.04% 425
2021
Q2
$755K Buy
+20,968
New +$774K 0.09% 250

Other funds holding GDRX

TwinBeech Capital's GDRX Position: Q3 2022 in Review

TwinBeech Capital sold out of GoodRx Holdings (GDRX) in Q3 2022, closing a stake of 81,581 shares — an estimated $483K sold.

TwinBeech Capital first reported a position in GDRX in Q2 2021 and held it in 4 quarters. The position peaked at $2.16M in Q4 2021. 180 funds tracked by Wall St. Rank hold GDRX as of Q3 2022.

  • TwinBeech Capital reported no remaining GoodRx Holdings position as of Q3 2022 after selling out during the quarter.
  • TwinBeech Capital sold 81,581 GoodRx Holdings shares in Q3 2022, an estimated $483K.
  • TwinBeech Capital first reported a position in GoodRx Holdings in Q2 2021 and held it in 4 quarters.
  • TwinBeech Capital's GoodRx Holdings position peaked at $2.16M in Q4 2021.
  • 180 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2022.

Based on TwinBeech Capital's 13F filing for Q3 2022, filed 14 Nov 2022.